• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

6.120 -0.200 (-3.16%)
Delayed Quote Updated: 4:00 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,765,955
Open 6.310
Bid (Size) 5.740 (500)
Ask (Size) 6.380 (100)
Prev. Close 6.320
Today's Range 5.990 - 6.385
52wk Range 3.310 - 6.385
Shares Outstanding 136,360,208
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year
November 05, 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript ↗
November 05, 2026
China weakness and litigation costs weighed on the quarter's results. 
Via The Motley Fool
Topics Earnings

Performance

52-Week Range 4.2% below 52-week high
6.120
3.3152W Low 6.3852W High
1 Week 4.2% below 1-week high
5.471W Low 6.381W High

Cytek Biosciences, Inc. - Common Stock (CTKB) traded between $3.31 and $6.38 over the past 52 weeks and last traded at $6.12, 4.2% below its 52-week high. Over the past week it ranged between $5.47 and $6.38.

Past 12 Months
+8.7%
+11.3%
+27.2%
+52.6%
+24.4%
+17.5%
1W +$0.49
1M +$0.62
3M +$1.31
6M +$2.11
YTD +$1.20
1Y +$0.91

CTKB was +17.5% over the past year, +52.6% over six months, +24.4% year to date, +8.7% in the last week.

12 Months vs Market
CTKB
+17.5%
DIA
+5.0%
SPY
+5.7%
QQQ
+3.9%
IWM
+12.0%

Over the past 12 months CTKB returned +17.5% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 1.35× 3-mo avg
Today 1,765,955 3-mo avg 1.3M
1W
1.4M
1M
1.3M
3M
1.3M
6M
1.3M
YTD
1.1M
1Y
1.1M

CTKB most recently traded 1,765,955 shares against a 3-month average daily volume of 1.3M.

More News

Read More
News headline image
Cytek Biosciences Q3 Earnings Call Highlights ↗
November 04, 2026
Via MarketBeat
Topics Earnings
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
February 26, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
News headline image
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
September 23, 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's pre-market session. ↗
September 23, 2026
Via Chartmill
News headline image
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
September 09, 2026
From Cytek Biosciences, Inc.; Sysmex Europe SE
Via GlobeNewswire
News headline image
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
September 03, 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek Biosciences Q2 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics Earnings
News headline image
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
July 15, 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
June 10, 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
June 02, 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
May 13, 2026
From USA News Group
Via GlobeNewswire
News headline image
Cytek (CTKB) Q1 2026 Earnings Call Transcript ↗
May 08, 2026
Via The Motley Fool
Topics Earnings
News headline image
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
March 09, 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗
February 27, 2026
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
November 14, 2025
Via Benzinga
News headline image
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
November 12, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
November 06, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗
November 05, 2025
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
October 29, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
October 15, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
September 10, 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cytek Biosciences, Inc. - Common Stock publicly traded?
Yes, Cytek Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Cytek Biosciences, Inc. - Common Stock trade on?
Cytek Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytek Biosciences, Inc. - Common Stock?
The ticker symbol for Cytek Biosciences, Inc. - Common Stock is CTKB on the Nasdaq Stock Market
What is the current price of Cytek Biosciences, Inc. - Common Stock?
The current price of Cytek Biosciences, Inc. - Common Stock is 6.120
When was Cytek Biosciences, Inc. - Common Stock last traded?
The last trade of Cytek Biosciences, Inc. - Common Stock was at 11/20/26 04:00 PM ET
What is the market capitalization of Cytek Biosciences, Inc. - Common Stock?
The market capitalization of Cytek Biosciences, Inc. - Common Stock is 834.52M
How many shares of Cytek Biosciences, Inc. - Common Stock are outstanding?
Cytek Biosciences, Inc. - Common Stock has 835M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap